For decades, the idea of resetting the biological clock sounded more like speculative fiction than clinical strategy. The discovery of Yamanaka factors by Nobel laureate Shinya Yamanaka, which can ...

Aging is the primary risk factor for numerous life-threatening diseases and has long been a central focus of biological research. Epigenetic reprogramming, a process that can modulate cell fate and ...

Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression. In gynecological malignancies-including ovarian, cervical, and ...

At the 12th Aging Research & Drug Discovery (ARDD) Meeting, which is being held this week in Copenhagen, Life Biosciences Inc. announced that it is developing its partial epigenetic reprogramming ...

MOUNTAIN VIEW, Calif., March 26, 2025 /PRNewswire/ -- Turn Biotechnologies, a pioneer in epigenetic reprogramming, announced the acquisition of groundbreaking ARMMs (ARRDC1 Mediated Microvesicles) ...

ARMMs brings precision medicine through targeted, non-viral vesicular delivery. Synergy of ARMMs and eTurna™ LNP platforms means company can deliver broad range of larger, more varied cargoes – ...

(Paris, France, Tuesday, 1 July 2025) Novel research presented today at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) has found that embryos from women ...